Putting patients in control
Our proven PURASORB® polymers are ideal resorbable excipients for controlled release drug delivery systems – enabling patients to control dosage over days, weeks, or months with a single injection.
PURASORB is safe, proven and effective.
Not only does the material benefit patients, but it also gives you maximum flexibility in formulation technologies - from extrusion and solvent processing to spray drying. All of which makes PURASORB the material of choice for the production of implants, microspheres, and gel depot systems.
Resorbable polymers for controlled release systems
When it comes to resorbable polymers for controlled release systems, our PURASORB solutions are available in PDLG (Poly DL-lactide/glycolide) and PDL (Poly DL-lactide) platforms.
Product not available in your region
This product is not available in the selected region.
If you want this product in your region, or find a suitable alternative, please contact us,
Corbion announces details of share buyback program
Corbion will execute a share buyback program of € 25 million in 2017. The share
Corbion publishes AGM agenda
Corbion has published its agenda for the upcoming annual shareholders meeting to be held on
Corbion full year 2016 results
Corbion reported sales of € 911.3 million in 2016, a decrease of 0.8%. Organic sales
Atlanta, Georgia, USA | The 2017 International Production and Processing Expo will bring together more than 1,200 exhibitors and
Plant Based Summit 2017
Lille, France | Hear Stephan Roest talk about biobased FDCA for PEF in packaging applications at Plant Based
1st International Biotechnology Congress (IBC-17)
Xi'an, China | Hear us speak at the IBC-17 in Xi'an, China next April.